Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. (Q54114563)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 1989

edit

Language	Label	Description	Also known as
English	Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.	scientific article published in January 1989

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

title

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

main subject

atrial fibrillation

0 references

aspirin

1 reference

based on heuristic

inferred from title

placebo

1 reference

based on heuristic

inferred from title

thromboembolism

1 reference

based on heuristic

inferred from title

(RS)-warfarin

1 reference

based on heuristic

inferred from title

prevention

1 reference

based on heuristic

inferred from title

author name string

P Petersen

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

G Boysen

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

J Godtfredsen

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

E D Andersen

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

B Andersen

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

language of work or name

English

0 references

publication date

1 January 1989

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

published in

The Lancet

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

volume

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

issue

8631

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

page(s)

175-179

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

uses

randomized experiment

0 references

cites work

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of atrial fibrillation and imminence of stroke: the Framingham study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke incidence and risk factors for stroke in Copenhagen, Denmark.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Silent cerebral infarction in chronic atrial fibrillation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Embolic complications in paroxysmal atrial fibrillation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation and stroke in elderly hospitalized patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The natural history of lone atrial fibrillation. A population-based study over three decades

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation revisited

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic ranges in anticoagulant administration

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A Multiple Testing Procedure for Clinical Trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

SYSTEMIC EMBOLISM AND ANTICOAGULANT PROPHYLAXIS IN RHEUMATIC HEART DISEASE.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitral valve disease, systemic embolism and anticoagulants

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Explanatory and pragmatic attitudes in therapeutical trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin for the primary prevention of myocardial infarction

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of platelet function by low-dose plain and micro-encapsulated acetylsalicylic acid

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991200-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0140-6736(89)91200-2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

PubMed publication ID

2563096

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2563096

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/2563096

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54114563&oldid=2104801517"